Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating magnetic resonance imaging features in active thyroid eye disease.
Kumar DA, Selvaraj JR, Balasubramaniam ST, Noronha V, Agarwal A. Kumar DA, et al. Among authors: noronha v. Indian J Ophthalmol. 2024 Dec 1;72(12):1822-1823. doi: 10.4103/IJO.IJO_3245_23. Epub 2024 Nov 29. Indian J Ophthalmol. 2024. PMID: 39620681 Free article. No abstract available.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer.
Lee SH, Menis J, Kim TM, Kim HR, Zhou C, Kurniawati SA, Prabhash K, Hayashi H, Lee DD, Imasa MS, Teh YL, Yang JC, Reungwetwattana T, Sriuranpong V, Wu CE, Ang Y, Sabando M, Thiagarajan M, Mizugaki H, Noronha V, Yulianti M, Zhang L, Smyth E, Yoshino T, Park JO, Pentheroudakis G, Park S, Peters S, Ahn JB, Popat S. Lee SH, et al. Among authors: noronha v. ESMO Open. 2024 Dec;9(12):103996. doi: 10.1016/j.esmoop.2024.103996. Epub 2024 Nov 29. ESMO Open. 2024. PMID: 39615406 Free PMC article.
Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance.
Khuntia SP, Mukherjee N, Javle V, Tanwar NA, Sreekanthreddy P, Varghese L, Gowda P, Kottlahouse A, Chandrani P, Choughule A, Pange P, Gupta V, Noronha V, Patil VM, Pramanik R, Kumar S, Nayak SP, Babu S, Shetty R, Kantharaju M, Chinder PS, Korlimarla A, Srinath BS, Prabhash K, Periyasamy G, Rishi KD, Goswami HM, Veldore VH. Khuntia SP, et al. Among authors: noronha v. JCO Glob Oncol. 2024 Nov;10:e2400289. doi: 10.1200/GO-24-00289. Epub 2024 Nov 21. JCO Glob Oncol. 2024. PMID: 39571115
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.
Prabhash K, Deshmukh C, Malhotra H, Sharma A, Jain M, Dhamne N, Nagarakar R, Ganesan P, Mahobia VK, Das CK, Kumar R, Shivanna PS, Avaronnan MP, Chaithanya PK, Chaudhary V, Singh K, Aagre S, Ravishankar B, Mehta D, Shilpa K, Maniar V, Chatterjee K, Majumdar SD, Dana R, Noronha V, Menon N, Sharma A, Pawar R, Shahavi V, Yadav R, Aiwale A. Prabhash K, et al. Among authors: noronha v. JCO Glob Oncol. 2024 Nov;10:e2400059. doi: 10.1200/GO.24.00059. Epub 2024 Nov 14. JCO Glob Oncol. 2024. PMID: 39541562 Clinical Trial.
Representation of female authors in oncology: the Indian perspective.
Noronha V, Kolkur M, Haridas C, Bhagyavant P, Das R, Chittari SS, Vasudevan L, Bafna G, Menon N, Shah M, Prabhash K. Noronha V, et al. Ecancermedicalscience. 2024 Sep 5;18:1755. doi: 10.3332/ecancer.2024.1755. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39430080 Free PMC article.
Predictive significance of inflammatory markers in the survival of older Indian patients with cancer: a single-center prospective analysis.
Rao AR, Noronha V, Ramaswamy A, Sekar A, Kumar A, Pillai A, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekale R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Kapoor A, Gota V, Banavali S, Badwe RA, Prabhash K. Rao AR, et al. Among authors: noronha v. Ecancermedicalscience. 2024 Aug 22;18:1746. doi: 10.3332/ecancer.2024.1746. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39421170 Free PMC article.
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial.
Murthy V, Maitre P, Bakshi G, Pal M, Singh M, Sharma R, Gudipudi D, Pujari L, Pandey H, Bandekar B, Joseph D, Krishnatry R, Phurailatpam R, Kannan S, Arora A, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Prakash G. Murthy V, et al. Among authors: noronha v. Int J Radiat Oncol Biol Phys. 2024 Sep 29:S0360-3016(24)03411-4. doi: 10.1016/j.ijrobp.2024.09.040. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39353477
421 results